In response to its recent analysis of the remote patient monitoring market, Frost & Sullivan is turning its attention to one company.
The venerable research company is recognizing Sentrian with the 2015 North American Frost & Sullivan Award for Technology Innovation.
If you’re not familiar, Sentrian aims to make a success of RPM with its remote patient intelligence (Sentrian RPI) solution (a data-driven system that can develop the complex algorithms necessary to extract additional value from RPM).
All told, the company hopes to transform data sets to actionable intelligence that will help detect health deterioration early and accurately, and increase the efficiency of remote care managers.
The Sentrian RPI is the first system to allow clinicians to rapidly build new remote disease deterioration models and uses machine learning to continuously enhance the models. As the platform is device- and gateway-agnostic, it can select the appropriate biosensors and less intrusive wearable devices to lower costs and improve compliance. The actual array is determined following a risk assessment for each patient.
“The essence of Sentrian’s solution is to enable scalability and avoid the deluge of unfiltered data that makes many potential RPM customers wary of large-scale solutions,” said Frost & Sullivan Industry Principal Analyst Victor Camlek.”Using advanced relationship-driven algorithms rather than merely flagging single-indicator readings, the company is expecting to overcome issues regarding scalability and, ultimately, boost the popularity of RPM.